Candidate drug replacements for quinacrine in cutaneous lupus erythematosus

Cutaneous lupus erythematosus (CLE) is a disfiguring and potentially disabling disease that causes significant morbidity in patients. Antimalarials are an important class of medication used to treat this disease and have been the first-line systemic therapy since the 1950s. Quinacrine, in particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Daisy, Borucki, Robert, Sontheimer, Richard D, Werth, Victoria P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577055/
https://www.ncbi.nlm.nih.gov/pubmed/33082164
http://dx.doi.org/10.1136/lupus-2020-000430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577055/
https://www.ncbi.nlm.nih.gov/pubmed/33082164
http://dx.doi.org/10.1136/lupus-2020-000430

Ejemplares similares